Hygea Medical Technology Co., Ltd., founded in 2010, is headquartered in Haidian District, Beijing, China. As a National High-tech Enterprise integrating R&D, production, sales and marketing, the company focuses on Interventional Oncology fields of "percutaneous intervention" and "transvascular intervention".The first released product, "Co-Ablation System", is leading the industry with the cutting-edge technology, the product introduces the first combined ablation system in the world by integrating cryoablation and hyperthermia ablation in one system. In 2020, Co-Ablation System obtained the CE Marking Certificate and started product marketing in European countries. The Co-Ablation System AI Epic series has won the iF DESIGN AWARD 2020.The company has set up Beijing Key Laboratory of Cryogenic Biomedical Engineering and Post-Doctoral Research Center. As to patents, the company obtains more than 150 patents both in China and abroad. Hygea Medical Technology Co., Ltd. was granted awards of the William Begell Medal, National Specialized and New "Little Giant" Enterprise, First Prize of Beijing Science and Technology Award, etc.We are committed to creating a minimally invasive treatment platform-type enterprise.
- 1st Workshop Building, Hygea, Beijing Satellite Manufactering Plant Park,No.63 Zhichun Road, Haidian, Beijing, China
- CsatlakozvaMarch 27, 2024
- website: www.hygeamedtech.com/
Sign up to follow @hygeamedtech
OR
If you already have an account,
By continuing, you agree to Wattpad's Terms of Service and Privacy Policy.
Stories by hygeamedtech
- 5 Published Stories
AI Epic™ Cryosurgical System
1
0
1
Integrates the advantages of cryoablation and hyperthermia ablation
for enhancing the minimally invasive canc...
CRYOSURGERY FOR PANCREAS CANCER
1
0
1
Cryoablation stands out as a highly effective palliative treatment option for individuals grappling with panc...
#30 in pancreatic
See all rankings
CRYOSURGERY FOR LIVER CANCER
1
0
1
Liver cancer cryoablation, a minimally invasive therapeutic procedure, has emerged as a promising option for...
#446 in liver
See all rankings